These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27699883)

  • 1. Susceptibility underestimation in a high-susceptibility phantom: Dependence on imaging resolution, magnitude contrast, and other parameters.
    Zhou D; Cho J; Zhang J; Spincemaille P; Wang Y
    Magn Reson Med; 2017 Sep; 78(3):1080-1086. PubMed ID: 27699883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced quantitative susceptibility mapping (QSM) using real-time field control.
    Özbay PS; Duerst Y; Wilm BJ; Pruessmann KP; Nanz D
    Magn Reson Med; 2018 Feb; 79(2):770-778. PubMed ID: 28556247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear paramagnetism-induced MR frequency shift and its implications for MR-based magnetic susceptibility measurement.
    Park J; Lee J; Park JY; Lee SK
    Magn Reson Med; 2017 Feb; 77(2):848-854. PubMed ID: 28019024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of low resolution and coverage on the accuracy of susceptibility mapping.
    Karsa A; Punwani S; Shmueli K
    Magn Reson Med; 2019 Mar; 81(3):1833-1848. PubMed ID: 30338864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase processing for quantitative susceptibility mapping of regions with large susceptibility and lack of signal.
    Fortier V; Levesque IR
    Magn Reson Med; 2018 Jun; 79(6):3103-3113. PubMed ID: 29130526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility weighted imaging and quantitative susceptibility mapping of the cerebral vasculature using ferumoxytol.
    Liu S; Brisset JC; Hu J; Haacke EM; Ge Y
    J Magn Reson Imaging; 2018 Mar; 47(3):621-633. PubMed ID: 28731570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSM reconstruction challenge 2.0: A realistic in silico head phantom for MRI data simulation and evaluation of susceptibility mapping procedures.
    Marques JP; Meineke J; Milovic C; Bilgic B; Chan KS; Hedouin R; van der Zwaag W; Langkammer C; Schweser F
    Magn Reson Med; 2021 Jul; 86(1):526-542. PubMed ID: 33638241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background field removal using a region adaptive kernel for quantitative susceptibility mapping of human brain.
    Fang J; Bao L; Li X; van Zijl PCM; Chen Z
    J Magn Reson; 2017 Aug; 281():130-140. PubMed ID: 28595120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sites.
    Hobson N; Polster SP; Cao Y; Flemming K; Shu Y; Huston J; Gerrard CY; Selwyn R; Mabray M; Zafar A; Girard R; Carrión-Penagos J; Chen YF; Parrish T; Zhou XJ; Koenig JI; Shenkar R; Stadnik A; Koskimäki J; Dimov A; Turley D; Carroll T; Awad IA
    J Magn Reson Imaging; 2020 Apr; 51(4):1192-1199. PubMed ID: 31515878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modulated closed form solution for quantitative susceptibility mapping--a thorough evaluation and comparison to iterative methods based on edge prior knowledge.
    Khabipova D; Wiaux Y; Gruetter R; Marques JP
    Neuroimage; 2015 Feb; 107():163-174. PubMed ID: 25463463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioned total field inversion (TFI) method for quantitative susceptibility mapping.
    Liu Z; Kee Y; Zhou D; Wang Y; Spincemaille P
    Magn Reson Med; 2017 Jul; 78(1):303-315. PubMed ID: 27464893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated and experimental phantom data for multi-center quality assurance of quantitative susceptibility maps at 3 T, 7 T and 9.4 T.
    Gustavo Cuña E; Schulz H; Tuzzi E; Biagi L; Bosco P; García-Fontes M; Mattos J; Tosetti M; Engelmann J; Scheffler K; Hagberg GE
    Phys Med; 2023 Jun; 110():102590. PubMed ID: 37116389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone quantitative susceptibility mapping using a chemical species-specific R2* signal model with ultrashort and conventional echo data.
    Dimov AV; Liu Z; Spincemaille P; Prince MR; Du J; Wang Y
    Magn Reson Med; 2018 Jan; 79(1):121-128. PubMed ID: 28261863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data.
    Chen J; Gong NJ; Chaim KT; Otaduy MCG; Liu C
    Neuroimage; 2021 Nov; 242():118477. PubMed ID: 34403742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results.
    Deistung A; Rauscher A; Sedlacik J; Stadler J; Witoszynskyj S; Reichenbach JR
    Magn Reson Med; 2008 Nov; 60(5):1155-68. PubMed ID: 18956467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast nonlinear susceptibility inversion with variational regularization.
    Milovic C; Bilgic B; Zhao B; Acosta-Cabronero J; Tejos C
    Magn Reson Med; 2018 Aug; 80(2):814-821. PubMed ID: 29322560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencing.
    Deh K; Kawaji K; Bulk M; Van Der Weerd L; Lind E; Spincemaille P; McCabe Gillen K; Van Auderkerke J; Wang Y; Nguyen TD
    Magn Reson Med; 2019 Feb; 81(2):1229-1236. PubMed ID: 30284727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of different phase unwrapping methods to optimize quantitative susceptibility mapping in the abdomen.
    Bechler E; Stabinska J; Wittsack HJ
    Magn Reson Med; 2019 Dec; 82(6):2077-2089. PubMed ID: 31317563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A regularized, model-based approach to phase-based conductivity mapping using MRI.
    Ropella KM; Noll DC
    Magn Reson Med; 2017 Nov; 78(5):2011-2021. PubMed ID: 28039883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward imaging the body at 10.5 tesla.
    Ertürk MA; Wu X; Eryaman Y; Van de Moortele PF; Auerbach EJ; Lagore RL; DelaBarre L; Vaughan JT; Uğurbil K; Adriany G; Metzger GJ
    Magn Reson Med; 2017 Jan; 77(1):434-443. PubMed ID: 27770469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.